GSK Tells 3rd Circ. Thalidomide Row Belongs In Fed. Court
GlaxoSmithKline PLC urged the Third Circuit on Wednesday to keep in federal court a suit alleging it hid evidence that morning sickness drug thalidomide caused birth defects, arguing that the company...To view the full article, register now.
Already a subscriber? Click here to view full article